Literature DB >> 9509183

Antimalarial effect in vitro and lack of modulating effect of desipramine and imipramine.

C M Menezes1, K Kirchgatter, S M Di Santi, C Savalli, F G Monteiro, G A Paula, E I Ferreira.   

Abstract

Based on previous studies in vitro of the modulating effect of desipramine on chloroquine-resistance of Plasmodium falciparum, the effect of desipramine and imipramine on freshly isolated resistant Brazilian strains of the parasite was investigated. Both drugs in therapeutic doses showed an unexpected antimalarial effect in vitro in duplicate tests (IC50 = 44.26 and 46.53 micrograms/L for desipramine, and 83.93 and 41.26 micrograms/L for imipramine), but no reversal of resistance when added to cultures together with chloroquine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9509183     DOI: 10.1016/s0035-9203(97)90529-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Structural analysis of chloroquine resistance reversal by imipramine analogs.

Authors:  A K Bhattacharjee; D E Kyle; J L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.

Authors:  Steven J Burgess; Audrey Selzer; Jane Xu Kelly; Martin J Smilkstein; Michael K Riscoe; David H Peyton
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

3.  5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.

Authors:  Christopher P Locher; Peter C Ruben; Jiri Gut; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.